Princeton Global Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Princeton Global Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$1K	–	576
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	530
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	540
2022 Q1	$3K	Hold	100	–	–	﹤0.01%	532
2021 Q4	$3K	Hold	100	–	–	﹤0.01%	473
2021 Q3	$4K	Hold	100	–	–	﹤0.01%	456
2021 Q2	$4K	Hold	100	–	–	﹤0.01%	477
2021 Q1	$3K	Hold	100	–	–	﹤0.01%	455
2020 Q4	$4K	Hold	100	–	–	﹤0.01%	434
2020 Q3	$2K	Hold	100	–	–	﹤0.01%	420
2020 Q2	$1K	Hold	100	–	–	﹤0.01%	498
2020 Q1	$2K	Hold	100	–	–	﹤0.01%	462
2019 Q4	$2	Hold	100	–	–	﹤0.01%	477
2019 Q3	$2K	Hold	100	–	–	﹤0.01%	336
2019 Q2	$3K	Buy	+100	New	+$2.26K	﹤0.01%	358

Other funds holding RIGL

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Princeton Global Asset Management's RIGL Position: Q4 2022 in Review

Princeton Global Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Princeton Global Asset Management first reported a position in RIGL in Q2 2019 and held it in 14 quarters. The position peaked at $4K in Q3 2021. 118 funds tracked by Wall St. Rank hold RIGL as of Q4 2022.

Princeton Global Asset Management reported no remaining Rigel Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Princeton Global Asset Management sold 100 Rigel Pharmaceuticals shares in Q4 2022, an estimated $1K.
Princeton Global Asset Management first reported a position in Rigel Pharmaceuticals in Q2 2019 and held it in 14 quarters.
Princeton Global Asset Management's Rigel Pharmaceuticals position peaked at $4K in Q3 2021.
118 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2022.

Based on Princeton Global Asset Management's 13F filing for Q4 2022, filed 6 Feb 2023.